Epileptic Channelopathies: 3rd Dianalund International Conference on Epilepsies

Epileptic channelopathies – clinical spectrum and treatment perspectives

Program and registration information

Inherited channelopathies account for a substantial fraction of epilepsy syndromes ranging from severe infantile encephalopathies to relatively benign focal epilepsies. Recent molecular genetic advances have contributed to our understanding of the pathophysiological mechanisms underlying these epileptic disorders.

Although epileptic channelopathies are individually rare, they can be accurately diagnosed by careful clinical assessment, appropriate laboratory investigations and DNA-based diagnosis. An accurate diagnosis is important for genetic counselling and to direct treatment options. Recently, some evidences showing that dysfunctional channels can be specifically targeted with drugs acting on them has suggested that a “precision medicine” approach may be promising, particularly in this groups of diseases where drug-resistance is common and evidence based treatment is lacking.

The main aims of this conference are to provide an updated overview of the currently recognized forms of epileptic channelopathies, to review the present knowledge on their pathogenetic mechanisms, and to discuss present and future therapeutic approaches.

Faculty

A Brunklaus (UK)
W Fazeli (Germany)
E Gardella (Denmark)
R Guerrini (Italy)
H Hjalgrim (Denmark)
KM Johannesen (Denmark)
B Koeleman (The Netherlands)
D Lal (USA)
J Lemke (Germany)
H Lerche (Germany)
D Lindhout (The Netherlands)
M Meisler (USA)
RS Møller (Denmark)
R Nabbout (France)
M Nikanorova (Denmark)
G Rubboli (Denmark)
S Sanders (USA)
S Sisodiya (UK)
S Syrbe(Germany)
P Veggiotti (Italy)
S Weckhuysen (Belgium)
M Wolff (Germany)

Organizing Committee

Alice B. Lyseen

Scientific Committee

Rikke S. Møller
Helle Hjalgrim
Elena Gardella
Guido Rubboli